77 related articles for article (PubMed ID: 1824850)
21. Inhibition of transformed T cell growth in vitro by monoclonal antibodies directed against distinct activating molecules.
Merćep M; Bluestone JA; Noguchi PD; Ashwell JD
J Immunol; 1988 Jan; 140(1):324-35. PubMed ID: 2891766
[TBL] [Abstract][Full Text] [Related]
22. cDNA cloning and sequencing of a novel monoclonal antibody to carcinoembryonic antigen and construction of a mouse/human chimeric antibody.
Shibaguchi H; Arakawa F; Imakiire T; Kuroki M; Kuroki M
Anticancer Res; 2003; 23(6a):4383-8. PubMed ID: 14666725
[TBL] [Abstract][Full Text] [Related]
23. Cloning and high level expression of a chimeric antibody with specificity for human carcinoembryonic antigen.
Beidler CB; Ludwig JR; Cardenas J; Phelps J; Papworth CG; Melcher E; Sierzega M; Myers LJ; Unger BW; Fisher M
J Immunol; 1988 Dec; 141(11):4053-60. PubMed ID: 3141512
[TBL] [Abstract][Full Text] [Related]
24. Activation properties of T cell receptor-gamma delta hybridomas expressing diversity in both gamma- and delta-chains.
Marusić-Galesić S; Pardoll DM; Saito T; Leo O; Fowlkes BJ; Coligan J; Germain RN; Schwartz RH; Kruisbeek AM
J Immunol; 1988 Jan; 140(2):411-8. PubMed ID: 3257236
[TBL] [Abstract][Full Text] [Related]
25. Regulation by anti-CD2 monoclonal antibody of the activation of a human T cell clone induced by anti-CD3 or anti-T cell receptor antibodies.
Yssel H; Aubry JP; de Waal Malefijt R; de Vries JE; Spits H
J Immunol; 1987 Nov; 139(9):2850-5. PubMed ID: 2444643
[TBL] [Abstract][Full Text] [Related]
26. Characterization of a monoclonal antibody which detects all murine alpha beta T cell receptors.
Kubo RT; Born W; Kappler JW; Marrack P; Pigeon M
J Immunol; 1989 Apr; 142(8):2736-42. PubMed ID: 2467936
[TBL] [Abstract][Full Text] [Related]
27. Proliferative capacity of senescent lymphocytes. II. Monoclonal antibody stimulation of mucosal and systemic lymphocytes via T cell activation molecules, CD3 epsilon, T cell receptor V beta 8 chain, and phosphatidylinositol-linked anchored receptors THY-1 and LY-6A.2/TAP.
Green-Johnson JM; Szewczuk MR
Reg Immunol; 1990-1991; 3(6):323-35. PubMed ID: 1983438
[TBL] [Abstract][Full Text] [Related]
28. Use of bispecific heteroconjugated antibodies (anti-T cell antigen receptor x anti-MHC class II) to study activation of T cells with a full length or truncated antigen receptor zeta-chain.
Wu S; Yang Y; Sadegh-Nasseri S; Ashwell JD
J Immunol; 1993 Mar; 150(6):2211-21. PubMed ID: 8450208
[TBL] [Abstract][Full Text] [Related]
29. In vivo administration of anti-CD3 monoclonal antibodies or immunotoxins in murine recipients of allogeneic T cell-depleted marrow for the promotion of engraftment.
Blazar BR; Hirsch R; Gress RE; Carroll SF; Vallera DA
J Immunol; 1991 Sep; 147(5):1492-503. PubMed ID: 1831826
[TBL] [Abstract][Full Text] [Related]
30. Use of I region-restricted, antigen-specific T cell hybridomas to produce idiotypically specific anti-receptor antibodies.
White J; Haskins KM; Marrack P; Kappler J
J Immunol; 1983 Mar; 130(3):1033-7. PubMed ID: 6185566
[TBL] [Abstract][Full Text] [Related]
31. Introduction of T cell receptor (TCR)-alpha cDNA has differential effects on TCR-gamma delta/CD3 expression by PEER and Lyon-1 cells.
De Waal Malefyt R; Alarcon B; Yssel H; Sancho J; Miyajima A; Terhorst CP; Spits H; De Vries JE
J Immunol; 1989 May; 142(10):3634-42. PubMed ID: 2523930
[TBL] [Abstract][Full Text] [Related]
32. Loss of original antigenic specificity in T cell hybridomas transduced with a chimeric receptor containing single-chain Fv of an anti-collagen antibody and Fc epsilonRI-signaling gamma subunit.
Annenkov AE; Moyes SP; Eshhar Z; Mageed RA; Chernajovsky Y
J Immunol; 1998 Dec; 161(12):6604-13. PubMed ID: 9862688
[TBL] [Abstract][Full Text] [Related]
33. Effects of anti-Lyt-2 and anti-L3T4 monoclonal antibodies on the function of cytotoxic T lymphocyte/helper T lymphocyte hybrid T cell clones.
Havran WL; Fitch FW
J Immunol; 1988 Sep; 141(6):1808-12. PubMed ID: 2459190
[TBL] [Abstract][Full Text] [Related]
34. T cell receptor alpha and beta gene expression in a murine antigen-specific T suppressor lymphocyte clone with cytolytic potential.
Heuer J; Degwert J; Pauels HG; Kölsch E
J Immunol; 1991 Jan; 146(2):775-82. PubMed ID: 1846162
[TBL] [Abstract][Full Text] [Related]
35. Expression of functional alpha beta T cell receptor gene rearrangements in suppressor T cell hybridomas correlates with antigen binding, but not with suppressor cell function.
Collins M; Kuchroo VK; Whitters MJ; O'Hara RM; Kelleher K; Kubo RT; Dorf ME
J Immunol; 1990 Nov; 145(9):2809-19. PubMed ID: 2170525
[TBL] [Abstract][Full Text] [Related]
36. The biologic activity of anti-T cell receptor V region monoclonal antibodies is determined by the epitope recognized.
Rojo JM; Janeway CA
J Immunol; 1988 Feb; 140(4):1081-8. PubMed ID: 2449495
[TBL] [Abstract][Full Text] [Related]
37. Construction, expression and characterization of a murine/human chimeric antibody with specificity for hepatitis B surface antigen.
Li YW; Lawrie DK; Thammana P; Moore GP; Shearman CW
Mol Immunol; 1990 Mar; 27(3):303-11. PubMed ID: 2342491
[TBL] [Abstract][Full Text] [Related]
38. Construction and expression of two mouse-human chimeric antibodies with high specificity and affinity for carcinoembryonic antigen.
Arakawa F; Haruno M; Kuroki M; Kanda H; Watanabe T; Misumi Y; Matsuoka Y
Hybridoma; 1993 Aug; 12(4):365-79. PubMed ID: 8244416
[TBL] [Abstract][Full Text] [Related]
39. Production of hybrid bispecific antibody recognizing human colorectal carcinoma and CD3 antigen.
Xiang J; Pan Z; Attah-Poku S; Babiuk L; Zhang Y; Liu E
Mol Biother; 1992 Mar; 4(1):15-23. PubMed ID: 1385710
[TBL] [Abstract][Full Text] [Related]
40. Development and functional characterization of a murine/human chimeric antibody with specificity for the human interleukin-2 receptor.
Vandevyver C; Steukers M; Lambrechts J; Heyligen H; Raus J
Mol Immunol; 1993 Jul; 30(10):865-76. PubMed ID: 8341281
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
